Alkermes
ALKS
#2383
Rank
โ‚ฌ6.95 B
Marketcap
41,39ย โ‚ฌ
Share price
-2.32%
Change (1 day)
63.55%
Change (1 year)

EPS for Alkermes (ALKS)

EPS in 2026 (TTM): -0,001935ย โ‚ฌ

According to Alkermes's latest financial reports the company's current EPS (TTM) is -0,0000000000ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 1,34ย โ‚ฌ a decrease over its 2024 EPS that were of 2,03ย โ‚ฌ.

EPS history for Alkermes from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,001935ย โ‚ฌ-100.14%
20251,34ย โ‚ฌ-34.08%
20242,03ย โ‚ฌ3.72%
20231,96ย โ‚ฌ-323.96%
2022-0,87ย โ‚ฌ220%
2021-0,27ย โ‚ฌ-57.19%
2020-0,64ย โ‚ฌ-44.38%
2019-1,15ย โ‚ฌ
2017-0,94ย โ‚ฌ-24.82%
2016-1,25ย โ‚ฌ-9.87%
2015-1,38ย โ‚ฌ660%
2014-0,18ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
6,08ย โ‚ฌ-12,033,301,387,828,043,776.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
4,78ย โ‚ฌ-9,457,550,908,645,464,064.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
0,65ย โ‚ฌ-1,279,021,170,502,529,280.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1,80ย โ‚ฌ-3,567,802,533,542,781,440.00%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
4,12ย โ‚ฌ-8,142,500,972,776,666,112.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
6,48ย โ‚ฌ-12,826,240,470,391,562,240.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Acorda Therapeutics
ACOR
-45,81ย โ‚ฌ 90,630,359,278,848,245,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
0,41ย โ‚ฌ-810,647,220,741,039,872.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel